Tao Sun Selected Research

human ERBB2 protein

1/2023	Pyrotinib in combination with letrozole for hormone receptor-positive, human epidermal growth factor receptor 2-positive metastatic breast cancer (PLEHERM): a multicenter, single-arm, phase II trial.
1/2023	Clinical efficacy of fulvestrant versus exemestane as first-line therapies for Chinese postmenopausal oestrogen-receptor positive /human epidermal growth factor receptor 2 -advanced breast cancer (FRIEND study).
8/2022	Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in China.
1/2022	Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
1/2022	Efficacy and safety of margetuximab plus chemotherapy vs. trastuzumab plus chemotherapy in Chinese patients with pretreated HER2-positive advanced metastatic breast cancer: results from a randomized, open-label, multicenter, phase II bridging study.
5/2021	Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equivalence Trial.
1/2021	Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China.
1/2021	Profile and outcome of receptor conversion in breast cancer metastases: a nation-wide multicenter epidemiological study.
1/2020	MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer: the multinational randomized phase III study.
1/2018	Overall Survival Benefit from Trastuzumab-Based Treatment in HER2-Positive Metastatic Breast Cancer: A Retrospective Analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tao Sun Research Topics

Disease

267	Neoplasms (Cancer) 05/2024 - 12/2004
83	Breast Neoplasms (Breast Cancer) 10/2023 - 02/2010
71	Inflammation (Inflammations) 04/2024 - 12/2004
60	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2010
55	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 03/2011
38	Pain (Aches) 01/2024 - 08/2005
32	Glioma (Gliomas) 01/2023 - 02/2005
30	Infections 12/2023 - 08/2004
23	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 01/2017
22	Ischemia 08/2022 - 06/2002
19	Triple Negative Breast Neoplasms 04/2024 - 03/2017
19	Hypoxia (Hypoxemia) 10/2023 - 05/2009
18	Epilepsy (Aura) 01/2023 - 05/2010
17	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 11/2012
16	Reperfusion Injury 01/2023 - 06/2002
15	Brain Neoplasms (Brain Tumor) 09/2023 - 06/2011
15	Seizures (Absence Seizure) 01/2022 - 02/2013
14	Neuralgia (Stump Neuralgia) 12/2023 - 02/2010
14	Disease Progression 11/2023 - 08/2015
14	Brain Ischemia (Cerebral Ischemia) 01/2023 - 02/2013
13	Stroke (Strokes) 03/2023 - 01/2011
13	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2007
12	Myocardial Infarction 01/2024 - 01/2008
12	Parkinson Disease (Parkinson's Disease) 12/2023 - 05/2006
12	Carcinogenesis 06/2023 - 01/2012
12	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2023 - 04/2017
12	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2014
11	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 06/2012
11	Glioblastoma (Glioblastoma Multiforme) 03/2023 - 01/2012
11	Wounds and Injuries (Trauma) 02/2023 - 01/2011
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 09/2007
10	Lung Neoplasms (Lung Cancer) 05/2024 - 08/2014
10	Cognitive Dysfunction 05/2024 - 02/2016
10	Obesity 11/2023 - 01/2007
10	Hemorrhage 12/2022 - 01/2020
9	Necrosis 05/2024 - 09/2008
9	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 06/2017
9	Stomach Neoplasms (Stomach Cancer) 06/2023 - 05/2007
9	Hyperalgesia 01/2023 - 02/2010
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 06/2018
9	Fibrosis (Cirrhosis) 01/2023 - 08/2005
9	Nervous System Diseases (Neurological Disorders) 01/2023 - 12/2011
9	AIDS-Related Complex (ARC) 02/2021 - 10/2010
8	Liver Neoplasms (Liver Cancer) 12/2023 - 01/2018
8	Adenocarcinoma 06/2023 - 01/2020
8	Neutropenia 05/2023 - 01/2020
8	Body Weight (Weight, Body) 03/2023 - 12/2011
8	Infarction (Infarctions) 01/2023 - 02/2013

Drug/Important Bio-Agent (IBA)

82	Proteins (Proteins, Gene)FDA Link 12/2023 - 08/2004
45	Biomarkers (Surrogate Marker)IBA 05/2024 - 02/2010
37	MicroRNAs (MicroRNA)IBA 05/2024 - 07/2010
29	CytokinesIBA 05/2024 - 02/2009
28	Messenger RNA (mRNA)IBA 12/2023 - 02/2005
26	Hormones (Hormone)IBA 09/2023 - 08/2014
21	Neuroprotective AgentsIBA 04/2024 - 09/2008
20	Therapeutic UsesIBA 12/2023 - 05/2007
20	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 09/2010
19	Peptides (Polypeptides)IBA 11/2023 - 08/2004
16	EnzymesIBA 04/2023 - 08/2005
16	MicellesIBA 01/2023 - 10/2016
15	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023 - 05/2008
15	Indicators and Reagents (Reagents)IBA 01/2023 - 08/2008
15	LipidsIBA 01/2023 - 11/2011
15	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 09/2008
12	ErbB Receptors (EGF Receptor)IBA 05/2024 - 01/2019
12	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024 - 01/2014
12	Inosine Triphosphate (ITP)IBA 01/2023 - 04/2017
12	human ERBB2 proteinIBA 01/2023 - 01/2015
12	Small Interfering RNA (siRNA)IBA 01/2022 - 05/2012
12	Oxygen (Dioxygen)IBA 12/2021 - 08/2012
11	RNA (Ribonucleic Acid)IBA 12/2024 - 06/2008
11	InflammasomesIBA 05/2024 - 01/2020
11	VaccinesIBA 12/2023 - 02/2012
10	AntioxidantsIBA 05/2024 - 04/2015
10	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2021
10	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 05/2007
10	Analgesics (Analgesic Drugs)IBA 12/2023 - 01/2012
10	Trastuzumab (Herceptin)FDA Link 10/2023 - 01/2015
10	Caspase 3 (Caspase-3)IBA 10/2023 - 01/2012
10	Transcription Factors (Transcription Factor)IBA 07/2023 - 11/2011
10	Adenosine Triphosphate (ATP)IBA 02/2023 - 05/2006
10	apatinibIBA 01/2023 - 01/2020
9	Bile Acids and Salts (Bile Acids)IBA 05/2024 - 02/2014
9	PolymersIBA 04/2024 - 03/2018
9	CholesterolIBA 03/2023 - 11/2011
9	Cisplatin (Platino)FDA LinkGeneric 12/2022 - 05/2007
9	Interleukin-6 (Interleukin 6)IBA 08/2022 - 07/2015
9	AntibodiesIBA 03/2022 - 05/2008
8	Sorafenib (BAY 43-9006)FDA Link 05/2024 - 01/2019
8	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 09/2007
8	HydrogelsIBA 01/2024 - 12/2016
8	LipopolysaccharidesIBA 10/2023 - 08/2007
8	Pilocarpine (Ocusert)FDA LinkGeneric 02/2023 - 07/2015
8	Long Noncoding RNAIBA 12/2022 - 01/2020

Therapy/Procedure

147	Therapeutics 04/2024 - 03/2002
60	Drug Therapy (Chemotherapy) 01/2024 - 03/2002
28	Immunotherapy 05/2024 - 01/2018
26	Radiotherapy 01/2024 - 01/2012
11	Aftercare (After-Treatment) 12/2023 - 01/2013
9	Precision Medicine 01/2023 - 11/2018